INTRODUCTION
Aspirin-induced asthma is a variant of an intrinsic asthma associated with intolerance of aspirin and/or non-steroidal anti-inflammatory drugs (NSAID). Nasal polyposis, with abundant tissue eosinophils, is a frequent finding in aspirin-induced asthma.1,2 A recent immunocytochemical study has demonstrated that eosinophils infiltrating nasal polyps are activated (EG2+).3 However, the mechanism of eosinophil infiltration into nasal polyps is unclear.
In the present report, we examine the eosinophil chemotactic activity of extracts from nasal polyps in a patient with aspirin-induced asthma. We focus upon interleukin (IL)-5 as a chemoattractant because IL-5 is one of the key cytokines for eosinophil recruitment and activation. 
METHODS
Peripheral blood eosinophils were isolated by discontinuous Percoll density gradient centrifugation followed by negative selection with immunomagnetic beads, as previously described.4 Briefly, heparinized blood was separated by sedimentation of erythrocytes with dextran for 30min. The granulocyte rich fraction was centrifuged for 30min through Percoll to reduce the number of neutrophils. The eosinophil-rich fraction was collected and labeled with anti-CD16 monoclonal were washed twice with Hanks' balanced salt solution containing 2% fetal calf serum and were incubated with sheep anti-mouse immunomagnetic dynabeads (Dynal, were subsequently removed using a magnetic particle concentrator (MPCTH-1; Dynal). Eosinophil purity exceeded 95% and showed a viability greater than 98% as judged by trypan blue exclusion. Chemotactic activity was assessed by a modified Boyden chamber assay using 48-well microchemotaxis chambers (Neuro Probe, Cabin John, MD, USA) as previously described. 5 In brief, cells were adjusted to in 5% CO2 air for 90min. Following incubation, the filter was fixed with methanol and was stained with Diff-Quick, (Kokusai Shiyaku, Kobe, Japan). Cells that passed through the filter to the lower surface were counted using a 10mm eyepiece graticule in a light microscope using Tissue extracts were prepared from nasal polyps of case 1 and were examined for the chemotactic response of the patient's peripheral blood eosinophils against these extracts. To determine whether IL-5 contributed to (Genzyme, Boston, MA, USA) was added to the lower chamber. We used recombinant human (rh)IL-3 and rhlL-5 in the eosinophil chemotaxis assay. A pellet of the extract was resuspended in RPMI-1640 supplemented with 2% FCS, washed and centrifuged for 30min through Percoll. The lymphocyte-rich fraction was collected and was labeled with magnetic cell sorter (MACS) CD3 Microbeads (Miltenyi Biotech, Bergisch Gladbach, passed through the MACS (Miltenyi Biotech), and positive selection was performed according to the manufacturer's instructions. Purity of CD3+ cells exceeded 95%. Serum and extract concentrations of IL-5 were determined by an enzyme-linked immunosorbent assay (ELISA) according to procedures as described previously.6
anti-human IL-5 serum was added to each well. After incubation for 4 h at room temperature, wells were conjugated goat anti-rabbit lgG (diluted 1:3000; BioRad, Hemel Hempstead, England) was added to each well. After incubation for 2 h at room temperature and washing, the chromogen was developed by adding the substrate O-phenylenediamine in the presence of 0.015% hydrogen peroxide for 20min. Reactions were optical densities (OD) were read at 490nm with an automated plate reader. The lower and upper limits of sensitivity of the assay were 100 and 40000pg/mL, respectively. No cross-reactivity was detected with IL-2, IL-3, IL-4, IL-6, or granulocyte-macrophage colony stimulating factor (GM-CSF). Standards were prepared from rhlL-5 purified on NC17-coupled beads from culture supernatants of Chinese hamster ovary cells transfected with human IL-5 cDNA.
Total cellular RNA was extracted from T lymphocytes with Isogen, according to the protocol of Nippon Gene (Tokyo, Japan), a modified guanidium thiocyanate single-step procedure. After isolation, the RNA was (GGCACTGCTTTCTACTCATCG).8 Peripheral blood lymphocytes from Kimura's disease and sterilized water were used as positive and negative controls for IL-5 mRNA expression, respectively.
RESULTS
Peripheral blood eosinophils obtained from a patient (case 1) with aspirin-induced asthma showed an increased chemotactic response against tissue extracts in a dose-dependent pattern (Fig. 1 ). This chemotactic response was inhibited by 40% when an antibody against IL-5 was added (Fig. 2) . As shown in Table 2 , IL-5 was detected in polyp extracts from both case 1 and case 2. Although serum concentrations of IL-5 in three normal volunteers were undetectable (data not shown), one patient (case 1) had a serum concentration of IL-5 above the lower limit of the ELISA. Furthermore, IL-5 was not detected in polyp extracts nor in sera from two patients with chronic sinusitis that was not associated with aspirininduced asthma or allergic diseases (data not shown). Figure 3 shows the chemotactic response of eosinophils isolated from the peripheral blood of patients and from a healthy individual to rhlL-3 (10-9mol/L) and rhlL-5 (10-9mol/L). Eosinophils isolated from these patients showed an increased chemotactic response to rhlL-5 compared with eosinophils from a normal subject. In contrast, chemotactic responses to rhlL-3 were increased both in asthmatic and in normal eosinophils. 
